Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU4 | INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) | GLAXOSMITHKLINE BIOLOGICALS | UNK | DJ22N | — |
maladministration expired vaccine/staff member administered an expire vaccine, expired 13-Jun-2025, to one of our staff members"; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 30-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2023-2024 season) (batch number DJ22N, expiry date 13-JUN-2025) for prophylaxis. On 07-OCT-2025, the patient received FluLaval Quadrivalent 2023-2024 season (unknown arm). On 07-OCT-2025, an unknown time after receiving FluLaval Quadrivalent 2023-2024 season, the patient experienced expired vaccine used (Verbatim: maladministration expired vaccine/staff member administered an expire vaccine, expired 13-Jun-2025, to one of our staff members"). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:08-OCT-2025 The reporter reported expired FluLaval administered to patient. Patient had not reported any adverse events to healthcare professional.